Company

Diag-Nose

respiratory biology startup

Melbourne, VIC

Investors

Every investor coverage indicates participated in a round Diag-Nose raised.

Investor	Rounds	Invested
No investors recorded yet. Know one?

On a portfolio page

Investors whose own portfolio pages list Diag-Nose, even though we haven't found any coverage of the round yet.

Investor	Listed on
Radar Ventures	its portfolio page ↗

What Diag-Nose bought

Companies Diag-Nose acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.

Company	Kind	Announced	Price	Sources
Diag-Nose is not recorded as having acquired anything.

Name	Role	Sources
Eldin Rostom	CEO	Startup Daily, @AuManufacturing

Coverage

Stories naming Diag-Nose. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

17 deals

2025 state of raising: $1.8 billion in – as late-stage deals boom

Tracxn figures show Australian tech funding reached $1.8 billion by mid-2025, powered by large late-stage rounds at Protecht, Airwallex, Harrison AI and Advancell, while seed and early-stage raising fell away sharply.

Unnamed stage $800k

Breakthrough Victoria invests $800,000 in Melbourne’s Diag-Nose.io to advance respiratory health

Breakthrough Victoria has put $800,000 into Diag-Nose.io Medical, a Melbourne respiratory health company whose RhinoMAP platform maps disease subtypes using a nasal biopsy device and AI; the firm began in a Stanford program.

@AuManufacturing 30 Jan 2025 Diag-Nose Stanford Breakthrough Victoria Eldin Rostom Lauren Morrey

Something wrong? Tell us